š“āā ļø Global has just published a new victim : Hangzhou Qihan Biotech Co., Ltd.
Brief
Qihan Biotech is a Hangzhouābased biotech company specializing in gene editing and cell/organ therapies. It develops immuneāprivileged cells and xenogeneic organs to treat cancer and organ failure. The company aims to make these therapies accessible worldwide.
